Exchange Bulletin

Arch Biopartners (ACH) To Trade On TSX Venture Exchange


February 20, 2015

ARCH BIOPARTNERS INC. ("ACH")
BULLETIN TYPE: New Listing-Shares
BULLETIN DATE: February 20, 2015
TSX Venture Tier 2 Company

Effective at the opening, Monday, February 23, 2015, the common shares of the
Company will commence trading on TSX Venture Exchange. The Company is
classified as a "Research and Development of Pharmaceutical Products" company.

Corporate Jurisdiction: Canada

Capitalization: Unlimited common shares with no par value of which
53,118,179 common shares are issued and outstanding

Escrowed Securities: Nil common shares

Transfer Agent: TMX Equity Transfer Services
Trading Symbol: ACH
CUSIP Number: 03938 C 104

For further information, please consult the Company's profile at www.sedar.com.

Company Contact: Richard Muruve, CEO and Director
Company Address: 27 St. Clair Avenue East, P.O. Box 305, Toronto, Ontario,
Canada M4T 2M5
Company Phone Number: 647-428-7031
Company Email Address: info@archbiopartners.com
Company Website: www.archbiopartners.com